• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

接受甲氧苄啶-磺胺甲恶唑预防类鼻疽的血液透析患者血流感染率较低。

Lower Rates of Bloodstream Infection in Patients on Hemodialysis Receiving Trimethoprim-Sulfamethoxazole Melioidosis Prophylaxis.

作者信息

Bryce Aliya, Davison Sara, Currie Bart J, Birrell Johanna M, Baird Robert W, Abeyaratne Asanga, Majoni Sandawana William, Brewster-O'Brien Teana, Tong Steven Y C

机构信息

Department of Infectious Diseases, Royal Darwin Hospital, Darwin, Northern Territory, Australia.

Department of General Medicine, Royal Melbourne Hospital, Melbourne, Victoria, Australia.

出版信息

Open Forum Infect Dis. 2024 Jul 31;11(8):ofae431. doi: 10.1093/ofid/ofae431. eCollection 2024 Aug.

DOI:10.1093/ofid/ofae431
PMID:39130084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11310582/
Abstract

Hemodialysis is a risk factor for bloodstream infection (SAB). In this single-center study, SAB rates were 56% lower during the monsoonal wet season when patients on hemodialysis receive supervised melioidosis prophylaxis with trimethoprim-sulfamethoxazole. This intervention may reduce SAB rates in high-risk patients; however, further targeted studies are required.

摘要

血液透析是血流感染（SAB）的一个危险因素。在这项单中心研究中，当接受血液透析的患者在季风雨季接受复方新诺明预防类鼻疽的监督治疗时，SAB发生率降低了56%。这种干预措施可能会降低高危患者的SAB发生率；然而，还需要进一步的针对性研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/11310582/6d7098755032/ofae431f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/11310582/ca52fdf870e7/ofae431_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/11310582/6d7098755032/ofae431f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/11310582/ca52fdf870e7/ofae431_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b89/11310582/6d7098755032/ofae431f1.jpg

相似文献

1
Lower Rates of Bloodstream Infection in Patients on Hemodialysis Receiving Trimethoprim-Sulfamethoxazole Melioidosis Prophylaxis.接受甲氧苄啶-磺胺甲恶唑预防类鼻疽的血液透析患者血流感染率较低。
Open Forum Infect Dis. 2024 Jul 31;11(8):ofae431. doi: 10.1093/ofid/ofae431. eCollection 2024 Aug.
2
Trimethoprim+Sulfamethoxazole Reduces Rates of Melioidosis in High-Risk Hemodialysis Patients.甲氧苄啶+磺胺甲恶唑可降低高危血液透析患者类鼻疽的发病率。
Kidney Int Rep. 2017 Sep 20;3(1):160-167. doi: 10.1016/j.ekir.2017.09.005. eCollection 2018 Jan.
3
Antibiotic Prophylaxis for Melioidosis in Patients Receiving Hemodialysis in the Tropics? One Size Does Not Fit All.热带地区接受血液透析患者的类鼻疽病抗生素预防？一刀切并不合适。
Am J Trop Med Hyg. 2018 Sep;99(3):597-600. doi: 10.4269/ajtmh.18-0421. Epub 2018 Jul 12.
4
Staphylococcus aureus Bacteremia Among Patients Receiving Maintenance Hemodialysis: Trends in Clinical Characteristics and Outcomes.金黄色葡萄球菌菌血症在维持性血液透析患者中的临床特征和结局变化趋势。
Am J Kidney Dis. 2022 Mar;79(3):393-403.e1. doi: 10.1053/j.ajkd.2021.06.018. Epub 2021 Jul 23.
5
A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis.一项关于甲氧苄啶-磺胺甲恶唑预防肾移植感染的前瞻性、随机、双盲研究：临床疗效、甲氧苄啶-磺胺甲恶唑的吸收、对微生物群的影响以及预防的成本效益。
Am J Med. 1990 Sep;89(3):255-74. doi: 10.1016/0002-9343(90)90337-d.
6
Trimethoprim-Sulfamethoxazole for Bacteremia Prophylaxis in Patients on Hemodialysis: A Future Tool for the "Swiss Army Knife" of Antibiotics?甲氧苄啶-磺胺甲恶唑用于血液透析患者的菌血症预防：抗生素“瑞士军刀”的未来工具？
Open Forum Infect Dis. 2024 Jul 31;11(8):ofae432. doi: 10.1093/ofid/ofae432. eCollection 2024 Aug.
7
Association Between Staphylococcus aureus Bacteremia and Hospital Mortality in Hemodialysis Patients With Bloodstream Infection: A Multicenter Cohort From Japanese Tertiary Care Centers.金黄色葡萄球菌菌血症与血液感染的血液透析患者医院死亡率之间的关联：来自日本三级医疗中心的多中心队列研究
Ther Apher Dial. 2017 Aug;21(4):354-360. doi: 10.1111/1744-9987.12534. Epub 2017 May 12.
8
Staphylococcus aureus bacteremia and buttonhole cannulation: long-term safety and efficacy of mupirocin prophylaxis.金黄色葡萄球菌菌血症和扣眼置管：莫匹罗星预防的长期安全性和疗效。
Clin J Am Soc Nephrol. 2010 Jun;5(6):1047-53. doi: 10.2215/CJN.00280110. Epub 2010 Apr 22.
9
Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study.低剂量复方磺胺甲噁唑预防未感染 HIV 的血液透析患者肺囊虫肺炎的安全性和疗效评价：一项回顾性观察研究。
BMC Infect Dis. 2021 Jul 8;21(1):664. doi: 10.1186/s12879-021-06374-3.
10
Preventing Staphylococcus aureus bacteremia and sepsis in patients with Staphylococcus aureus colonization of intravascular catheters: a retrospective multicenter study and meta-analysis.预防血管内导管金黄色葡萄球菌定植患者发生金黄色葡萄球菌菌血症和脓毒症：一项回顾性多中心研究及荟萃分析。
Medicine (Baltimore). 2011 Jul;90(4):284-288. doi: 10.1097/MD.0b013e31822403e9.

引用本文的文献

1
Analysis of Drug-Resistant Bacteria Seasonality in Japan Using Financial Time Series Analysis Method: A Nationwide Longitudinal Study.运用金融时间序列分析方法对日本耐药菌季节性的分析：一项全国性纵向研究。
Can J Infect Dis Med Microbiol. 2025 Feb 28;2025:5590467. doi: 10.1155/cjid/5590467. eCollection 2025.
2
The Incidence, Aetiology and Clinical Course of Serious Infections Complicating Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drug Therapy in Patients with Rheumatoid Arthritis in Tropical Australia.澳大利亚热带地区类风湿关节炎患者生物制剂和靶向合成改善病情抗风湿药物治疗并发严重感染的发病率、病因及临床病程
Pathogens. 2024 Oct 29;13(11):943. doi: 10.3390/pathogens13110943.
3

本文引用的文献

1
Vital Signs: Health Disparities in Hemodialysis-Associated Staphylococcus aureus Bloodstream Infections - United States, 2017-2020.生命体征：2017-2020 年美国血液透析相关性金黄色葡萄球菌血流感染中的健康差异。
MMWR Morb Mortal Wkly Rep. 2023 Feb 10;72(6):153-159. doi: 10.15585/mmwr.mm7206e1.
2
Invasive group A streptococcal disease in the Northern Territory and the impact of melioidosis antibiotic prophylaxis.
Med J Aust. 2022 Nov 21;217(10):544-545. doi: 10.5694/mja2.51739. Epub 2022 Sep 29.
3
Staphylococcus aureus colonization increases the risk of bacteremia in hemodialysis patients: a molecular epidemiology approach with time-dependent analysis.金黄色葡萄球菌定植增加血液透析患者菌血症风险：一项基于时间依赖性分析的分子流行病学研究。
The characteristics and clinical course of patients with melioidosis and cancer.
类鼻疽病合并癌症患者的特征和临床病程。
PLoS Negl Trop Dis. 2024 Oct 25;18(10):e0012631. doi: 10.1371/journal.pntd.0012631. eCollection 2024 Oct.
4
Trimethoprim-Sulfamethoxazole for Bacteremia Prophylaxis in Patients on Hemodialysis: A Future Tool for the "Swiss Army Knife" of Antibiotics?甲氧苄啶-磺胺甲恶唑用于血液透析患者的菌血症预防：抗生素“瑞士军刀”的未来工具？
Open Forum Infect Dis. 2024 Jul 31;11(8):ofae432. doi: 10.1093/ofid/ofae432. eCollection 2024 Aug.
Am J Infect Control. 2021 Feb;49(2):215-223. doi: 10.1016/j.ajic.2020.05.031. Epub 2020 May 31.
4
Oral eradication therapy for melioidosis: Important but not without risks.口服清除疗法治疗类鼻疽：重要但并非没有风险。
Int J Infect Dis. 2019 Mar;80:111-114. doi: 10.1016/j.ijid.2019.01.019. Epub 2019 Jan 16.
5
Trimethoprim+Sulfamethoxazole Reduces Rates of Melioidosis in High-Risk Hemodialysis Patients.甲氧苄啶+磺胺甲恶唑可降低高危血液透析患者类鼻疽的发病率。
Kidney Int Rep. 2017 Sep 20;3(1):160-167. doi: 10.1016/j.ekir.2017.09.005. eCollection 2018 Jan.
6
Host-microbe interplay in persistent Staphylococcus aureus nasal carriage in HIV patients.HIV患者金黄色葡萄球菌鼻腔持续携带中的宿主-微生物相互作用
Microbes Infect. 2008 Feb;10(2):151-8. doi: 10.1016/j.micinf.2007.10.017. Epub 2007 Nov 9.
7
Prophylaxis with trimethoprim-sulfamethoxazole for human immunodeficiency virus-infected patients: impact on risk for infectious diseases.对人类免疫缺陷病毒感染患者采用甲氧苄啶-磺胺甲恶唑进行预防：对传染病风险的影响。
Clin Infect Dis. 2001 Aug 1;33(3):393-8. doi: 10.1086/321901. Epub 2001 Jun 25.
8
Community-acquired bacteremia in HIV-positive patients: protective benefit of co-trimoxazole.
AIDS. 1996 Dec;10(14):1635-9. doi: 10.1097/00002030-199612000-00007.